Program Detail
Modality
Program #
Program
indication
Presentation
Source
Human metapneumovirus and parainfluenza virus 3 (hMPV/PIV3) vaccine
Last program update Oct 29, 2020
Source
Pediatric respiratory syncytial virus (RSV) vaccine \n\iFuture respiratory combo/i
Last program update Oct 29, 2020
Source
Influenza vaccine
Last program update Jan 11, 2021
Source
Personalized Cancer Vaccine (PCV) \n\iSolid tumors/i
Last program update Oct 29, 2020
Source
KRAS vaccine \n\iCRC, NSCLC, pancreatic cancer/i
Last program update Oct 29, 2020
Source
OX40L \n\iSolid tumors/lymphoma/i\n\iAdvanced ovarian carcinoma/i
Last program update Oct 29, 2020
Source
OX40L/IL-23/IL-36y \n\iSolid tumors/lymphoma/i
Last program update Oct 29, 2020